Addex Therapeutics Statistics

Total Valuation

ADXN has a market cap or net worth of $35.42 million. The enterprise value is $30.57 million.

Market Cap	35.42M
Enterprise Value	30.57M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

ADXN has 1.43 million shares outstanding.

Shares Outstanding	1.43M
Owned by Insiders (%)	n/a
Owned by Institutions (%)	18.49%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.80
Forward PS	n/a
PB Ratio	8.20
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.08.

Current Ratio	2.97
Quick Ratio	2.56
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.41

Financial Efficiency

Return on equity (ROE) is -238.30% and return on invested capital (ROIC) is -260.03%.

Return on Equity (ROE)	-238.30%
Return on Assets (ROA)	-147.80%
Return on Capital (ROIC)	-260.03%
Revenue Per Employee	$93,393
Profits Per Employee	-$514,085
Employee Count	24
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.20% in the last 52 weeks. The beta is 1.76, so ADXN's price volatility has been higher than the market average.

Beta (1Y)	1.76
52-Week Price Change	+66.20%
50-Day Moving Average	13.00
200-Day Moving Average	9.42
Relative Strength Index (RSI)	76.46
Average Volume (30 Days)	16,203

Short Selling Information

Short Interest	8,698
Short Previous Month	11,891
Short % of Shares Out	0.05%
Short % of Float	n/a
Short Ratio (days to cover)	1.18

Income Statement

In the last 12 months, ADXN had revenue of $2.24 million and -$12.34 million in losses. Loss per share was -$0.16.

Revenue	2.24M
Gross Profit	2.26M
Operating Income	-12.16M
Pretax Income	-12.44M
Net Income	-12.34M
EBITDA	-11.74M
EBIT	-12.08M
Loss Per Share	-$0.16

Full Income Statement

Balance Sheet

The company has $5.21 million in cash and $354,254 in debt, giving a net cash position of $4.86 million or $3.39 per share.

Cash & Cash Equivalents	5.21M
Total Debt	354,254
Net Cash	4.86M
Net Cash Per Share	$3.39
Equity / Book Value	4.32M
Book Value Per Share	3.02
Working Capital	4.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.44 million and capital expenditures -$6,177, giving a free cash flow of -$11.45 million.

Operating Cash Flow	-11.44M
Capital Expenditures	-6,177
Free Cash Flow	-11.45M
FCF Per Share	-$18.34

Full Cash Flow Statement

Margins

Gross margin is 100.80%, with operating and profit margins of -542.48% and -550.45%.

Gross Margin	100.80%
Operating Margin	-542.48%
Pretax Margin	-554.88%
Profit Margin	-550.45%
EBITDA Margin	-523.98%
EBIT Margin	-538.75%
FCF Margin	-510.68%

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.79%
Shareholder Yield	-97.79%
Earnings Yield	-34.83%
FCF Yield	-32.32%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	19.20%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 23, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Oct 23, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

ADXN has an Altman Z-Score of -77.56 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-77.56
Piotroski F-Score	4